Diabetes

Diabetes overview

Addressing the challenge of diabetes

Diabetes is a significant, multifaceted condition, with 8.4M+ people estimated to be living with autoimmune T1D worldwide.¹ Patients face continuous management, the threat of acute and chronic complications, and the ongoing emotional burden of a chronic illness. To address these complex challenges, global research initiatives are continually striving for advancements to alleviate the burden and improve patient quality of life.

Don’t miss these key links

BR1DGE: Type 1 Diabetes Education ADA 2024 Congress Report

Supporting diabetes management through information

For healthcare professionals, staying informed about diabetes and evolving patient needs is crucial for providing the best possible care. The international scientific community is actively investigating several broad areas within type 1 diabetes research:

Autoimmunity: Research aims to understand and interrupt the immune system's attack
Beta cells: Efforts focus on restoring or replacing insulin-producing cells
Glycemic control: The goal is to optimize blood sugar management and reduce daily burden
Complications: Work centers on preventing and treating long-term health issues
Psychosocial aspects: Initiatives address the mental and social impact of living with T1D

Register as a healthcare professional today to gain full access to the latest diabetes research, curated resources, and education.

Get full access

How Immunoscience is Transforming Treatment for Type 1 Diabetes

November 2022 was a turning point for type 1 diabetes (T1D). After more than 100 years of insulin treatment, patients and doctors now had a new option: the first disease-modifying therapy offered in T1D.

Find out more

Facts about diabetes in Australia

For healthcare professionals in Australia, having a clear picture of the disease's impact is essential to provide effective, compassionate care.

As of 2022, over 1.5 million Australians (6.0% of the population) were living with diagnosed diabetes.*

In 2022, diabetes was mentioned as an associated cause in 22% of all deaths in Australia.* 

In 2022, 20.5% (almost 1 in 5) of women who gave birth had gestational diabetes.†

In 2021–22, 9.9% of all hospitalisations (1.2 million) were associated with diabetes.‡

*Australian Institute of Health and Welfare. Diabetes: Overview [Internet]. Canberra: AIHW; 2024 Oct 16 [cited 2025 May 22]. Available from: https://www.aihw.gov.au/reports-data/health-conditions-disability-deaths/diabetes/overview
†Australian Institute of Health and Welfare. Australia's mothers and babies 2022 [Internet]. Canberra: AIHW; 2024 Sep 28 [cited 2025 May 22]. Available from: https://www.aihw.gov.au/reports/mothers-babies/australias-mothers-and-babies-2022
‡Australian Institute of Health and Welfare. Diabetes: Hospitalisations [Internet]. Canberra: AIHW; 2024 Oct 16 [cited 2025 May 22]. Available from: https://www.aihw.gov.au/reports-data/health-conditions-disability-deaths/diabetes/hospitalisations

Featured content

Register to receive full access

Are you a registered healthcare professional?
Register in less than a minute to access the latest updates and resources to support your practice and help deliver better outcomes for your patients.

Log in Register here